Clinical Trial Update: Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing tigecycline to levofloxacin in hospitalized patients with community-acquired pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Pneumonia
• Community-acquired Pneumonia

Drugs mentioned

• Levofloxacin (Levofloxacin)
• Tigecycline (tigecycline)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Community Acquired Pneumonia, Bacterial Pneumonia | Phase 3 | Status: COMPLETED